In Treatment of Gastroesophageal reflux disease (Acid reflux) Gastroesophageal reflux disease (GERD) is a chronic (long-term) condition in which there is an excess production of acid in the stomach. Kzra D 40 Capsule SR reduces the amount of acid your stomach makes and relieves the pain associated with heartburn and acid reflux. You should take it exactly as it is prescribed for it to be effective. Some simple lifestyle changes can help reduce the symptoms of GERD. Think about what foods trigger heartburn and try to avoid them; eat smaller, more frequent meals; try to lose weight if you are overweight and try to find ways to relax. Do not eat within 3-4 hours of going to bed. In Treatment of Functional dyspepsia Functional dyspepsia is another term for indigestion that is not associated with a specific cause. It may cause symptoms such as an early feeling of fullness after eating, stomach pain or discomfort, nausea, and bloating. Kzra D 40 Capsule SR helps treat these symptoms by increasing the rate of stomach emptying. Follow your doctor’s instructions carefully and make appropriate lifestyle changes to get maximum benefit.
Caution is advised when consuming alcohol with Kzra D 40 Capsule SR. Please consult your doctor.
Kzra D 40 Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Kzra D 40 Capsule SR is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Kzra D 40 Capsule SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kzra D 40 Capsule SR should be used with caution in patients with kidney disease. Dose adjustment of Kzra D 40 Capsule SR may be needed. Please consult your doctor.
Kzra D 40 Capsule SR should be used with caution in patients with liver disease. Dose adjustment of Kzra D 40 Capsule SR may be needed. Please consult your doctor. Use of Kzra D 40 Capsule SR is not recommended in patients with moderate and severe liver disease.
If you miss a dose of Kzra D 40 Capsule SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Radicool Pharmaceutical Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ambic Ayurchem Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Assure Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Corona Remedies Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Jupiter Biolabs Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Medocean Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pranyog Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Jodiac Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Care Formulation Labs Pvt Ltd || ₹14.5/tablet (25% cheaper)